Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “ADC”
A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.
ClinicalTrials.gov study NCT03894150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor
ClinicalTrials.gov study NCT05628857. IPD Sharing: NO. Countries: 1. Publications: 0.
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
ClinicalTrials.gov study NCT06797999. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer
ClinicalTrials.gov study NCT06155396. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
ClinicalTrials.gov study NCT07360314. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer
ClinicalTrials.gov study NCT04264936. IPD Sharing: NO. Countries: 1. Publications: 0.
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)
ClinicalTrials.gov study NCT03504488. IPD Sharing: UNDECIDED. Countries: 6. Publications: 0.
TR1801-ADC in Patients With Tumors That Express c-Met
ClinicalTrials.gov study NCT03859752. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
ClinicalTrials.gov study NCT07268053. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Parti
ClinicalTrials.gov study NCT04300556. IPD Sharing: YES. Countries: 5. Publications: 0.
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors
ClinicalTrials.gov study NCT06769152. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging
ClinicalTrials.gov study NCT06715020. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
ClinicalTrials.gov study NCT06908928. IPD Sharing: NO. Countries: 1. Publications: 0.
RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT05996952. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Study of Mesothelin-ADC
ClinicalTrials.gov study NCT02884726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC
ClinicalTrials.gov study NCT05834686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
ClinicalTrials.gov study NCT05941507. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum
ClinicalTrials.gov study NCT06791070. IPD Sharing: NO. Countries: 1. Publications: 0.
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
ClinicalTrials.gov study NCT06649331. IPD Sharing: NO. Countries: 1. Publications: 0.
ABBV-319: A First-In-Class CD19-targeting Glucocorticoid Receptor Modulator (GRM) Agonist Antibody-Drug Conjugate (ADC) for the Treatment of B-cell Malignancies
GEO Series GSE249543. Homo sapiens. 18 samples. Type: Expression profiling by high throughput sequencing; Other.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.